RadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock?

Zacks
Zacksで開く
RadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock?

RadNet RDNT shares ended the last trading session 9.7% higher at $80.26. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.1% gain over the past four weeks.

RadNet recorded a strong price rise on investors’ optimism surrounding its impending third-quarter 2026 financial results, slated to release on Nov. 9. In the previous quarter, the company’s revenue increased 25% year over year, with the Digital Health segment growing 56.5%. RadNet also signed new business with Total Contract Value of nearly $21 million, bringing its six-month new business Total Contract Value to approximately $37 million.

This operator of medical diagnostic imaging centers is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents a year-over-year change of +5%. Revenues are expected to be $637.56 million, up 21.9% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For RadNet, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RDNT going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

RadNet belongs to the Zacks Medical - Outpatient and Home Healthcare industry. Another stock from the same industry, Aveanna Healthcare AVAH, closed the last trading session 7.2% higher at $14.23. Over the past month, AVAH has returned 8.7%.

For Aveanna, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.2. This represents a change of +33.3% from what the company reported a year ago. Aveanna currently has a Zacks Rank of #2 (Buy).

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
RadNet, Inc. (RDNT): Free Stock Analysis Report
 
Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research